Global Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2031

Summary

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

According to APO Research, The global Therapeutic Drug Monitoring market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Therapeutic Drug Monitoring is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Therapeutic Drug Monitoring is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Therapeutic Drug Monitoring is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Therapeutic Drug Monitoring include Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Sanquin and Becton Dickinson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.

The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Therapeutic Drug Monitoring Segment by Company

Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics

Therapeutic Drug Monitoring Segment by Type

Blood Test
Urine Test
Saliva Test
Other Test

Therapeutic Drug Monitoring Segment by Application

Hospital Labs
Private Labs
Others

Therapeutic Drug Monitoring Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Therapeutic Drug Monitoring companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Therapeutic Drug Monitoring Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Therapeutic Drug Monitoring Market Size by Region (2020-2031)
1.4.1 Global Therapeutic Drug Monitoring Market Size by Region (2020-2025)
1.4.2 Global Therapeutic Drug Monitoring Market Size by Region (2026-2031)
1.5 Key Regions Therapeutic Drug Monitoring Market Size (2020-2031)
1.5.1 North America Therapeutic Drug Monitoring Market Size Growth Rate (2020-2031)
1.5.2 Europe Therapeutic Drug Monitoring Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (2020-2031)
1.5.4 South America Therapeutic Drug Monitoring Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (2020-2031)
2 Therapeutic Drug Monitoring Market by Type

2.1 Type Introduction
2.1.1 Blood Test
2.1.2 Urine Test
2.1.3 Saliva Test
2.1.4 Other Test
2.2 Global Therapeutic Drug Monitoring Market Size by Type
2.2.1 Global Therapeutic Drug Monitoring Market Size Overview by Type (2020-2031)
2.2.2 Global Therapeutic Drug Monitoring Historic Market Size Review by Type (2020-2025)
2.2.3 Global Therapeutic Drug Monitoring Market Size Forecasted by Type (2026-2031)
2.3 Global Therapeutic Drug Monitoring Market Size by Regions
2.3.1 North America Therapeutic Drug Monitoring Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Therapeutic Drug Monitoring Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Type (2020-2025)
2.3.4 South America Therapeutic Drug Monitoring Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Type (2020-2025)
3 Therapeutic Drug Monitoring Market by Application

3.1 Type Introduction
3.1.1 Hospital Labs
3.1.2 Private Labs
3.1.3 Others
3.2 Global Therapeutic Drug Monitoring Market Size by Application
3.2.1 Global Therapeutic Drug Monitoring Market Size Overview by Application (2020-2031)
3.2.2 Global Therapeutic Drug Monitoring Historic Market Size Review by Application (2020-2025)
3.2.3 Global Therapeutic Drug Monitoring Market Size Forecasted by Application (2026-2031)
3.3 Global Therapeutic Drug Monitoring Market Size by Regions
3.3.1 North America Therapeutic Drug Monitoring Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Therapeutic Drug Monitoring Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Breakdown by Application (2020-2025)
3.3.4 South America Therapeutic Drug Monitoring Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Therapeutic Drug Monitoring Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics

4.1 Therapeutic Drug Monitoring Industry Trends
4.2 Therapeutic Drug Monitoring Industry Drivers
4.3 Therapeutic Drug Monitoring Industry Opportunities and Challenges
4.4 Therapeutic Drug Monitoring Industry Restraints
5 Competitive Insights by Company

5.1 Global Top Players by Therapeutic Drug Monitoring Revenue (2020-2025)
5.2 Global Therapeutic Drug Monitoring Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Therapeutic Drug Monitoring Key Company Headquarters & Area Served
5.4 Global Therapeutic Drug Monitoring Company, Product Type & Application
5.5 Global Therapeutic Drug Monitoring Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Therapeutic Drug Monitoring Market CR5 and HHI
5.6.2 Global Top 5 and 10 Therapeutic Drug Monitoring Players Market Share by Revenue in 2024
5.6.3 2024 Therapeutic Drug Monitoring Tier 1, Tier 2, and Tier 3
6 Company Profiles

6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
6.1.5 Roche Recent Developments
6.2 Danaher
6.2.1 Danaher Comapny Information
6.2.2 Danaher Business Overview
6.2.3 Danaher Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
6.2.5 Danaher Recent Developments
6.3 Abbott
6.3.1 Abbott Comapny Information
6.3.2 Abbott Business Overview
6.3.3 Abbott Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
6.3.5 Abbott Recent Developments
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Comapny Information
6.4.2 Thermo Fisher Scientific Business Overview
6.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Comapny Information
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
6.5.5 Siemens Healthcare Recent Developments
6.6 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Comapny Information
6.6.2 Bio-Rad Laboratories Business Overview
6.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
6.6.5 Bio-Rad Laboratories Recent Developments
6.7 BioMerieux
6.7.1 BioMerieux Comapny Information
6.7.2 BioMerieux Business Overview
6.7.3 BioMerieux Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
6.7.5 BioMerieux Recent Developments
6.8 Sanquin
6.8.1 Sanquin Comapny Information
6.8.2 Sanquin Business Overview
6.8.3 Sanquin Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
6.8.5 Sanquin Recent Developments
6.9 Becton Dickinson
6.9.1 Becton Dickinson Comapny Information
6.9.2 Becton Dickinson Business Overview
6.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
6.9.5 Becton Dickinson Recent Developments
6.10 Quest Diagnostics
6.10.1 Quest Diagnostics Comapny Information
6.10.2 Quest Diagnostics Business Overview
6.10.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
6.10.5 Quest Diagnostics Recent Developments
7 North America

7.1 North America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Therapeutic Drug Monitoring Market Size by Country (2020-2025)
7.3 North America Therapeutic Drug Monitoring Market Size Forecast by Country (2026-2031)
8 Europe

8.1 Europe Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Therapeutic Drug Monitoring Market Size by Country (2020-2025)
8.3 Europe Therapeutic Drug Monitoring Market Size Forecast by Country (2026-2031)
9 Asia-Pacific

9.1 Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2020-2025)
9.3 Asia-Pacific Therapeutic Drug Monitoring Market Size Forecast by Country (2026-2031)
10 South America

10.1 South America Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Therapeutic Drug Monitoring Market Size by Country (2020-2025)
10.3 South America Therapeutic Drug Monitoring Market Size Forecast by Country (2026-2031)
11 Middle East & Africa

11.1 Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2020-2025)
11.3 Middle East & Africa Therapeutic Drug Monitoring Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings